Richard A. Zordani Jr., Director at GALECTIN THERAPEUTICS INC (GALT), bought 10,000 shares at $0.82 ($8K) on 2024-12-24, disclosed to the SEC on 2024-12-26.
Open-market purchase of $8k GALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| GALT | BUY | 2022-07-29 | $13K | — | Filing → |
| GALT | BUY | 2022-04-04 | $8K | — | Filing → |
| GALT | BUY | 2022-01-18 | $10K | — | Filing → |